These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33963718)

  • 1. [Correlation of cerebrospinal fluid amyloid β-protein 42 and neurofilament light protein levels with postoperative neurocognitive dysfunction in elderly patients].
    Zhang X; Fu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):574-578. PubMed ID: 33963718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The predictive value of melanin-concentrating hormone combined with other related biomarkers in cerebrospinal fluid in preoperative cognitive dysfunction of elderly patients].
    Gao Y; Zhao YJ; Li Y; Song JN; Zhang XZ; Sun Y; Yu M; Zhou Q
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2772-2777. PubMed ID: 37723051
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative cerebrospinal fluid biomarkers may be associated with postoperative delirium in patients undergoing knee/hip arthroplasty: the PNDABLE study.
    Lin Y; Yu N; Lin X; Deng X; Liu F; Tao H; Dong R; Wang B; Bi Y
    BMC Geriatr; 2023 May; 23(1):282. PubMed ID: 37165310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease.
    Dhiman K; Gupta VB; Villemagne VL; Eratne D; Graham PL; Fowler C; Bourgeat P; Li QX; Collins S; Bush AI; Rowe CC; Masters CL; Ames D; Hone E; Blennow K; Zetterberg H; Martins RN
    Alzheimers Dement (Amst); 2020; 12(1):e12005. PubMed ID: 32211500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilament light chain in the vitreous humor of the eye.
    Subramanian ML; Vig V; Chung J; Fiorello MG; Xia W; Zetterberg H; Blennow K; Zetterberg M; Shareef F; Siegel NH; Ness S; Jun GR; Stein TD
    Alzheimers Res Ther; 2020 Sep; 12(1):111. PubMed ID: 32943089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
    Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM
    JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurofilament light predicts the rate of executive function decline in younger-onset dementia.
    Walia N; Eratne D; Loi SM; Li QX; Varghese S; Malpas CB; Walterfang M; Evans AH; Parker S; Collins SJ; Masters CL; Velakoulis D
    J Neurol Sci; 2022 Jan; 432():120088. PubMed ID: 34922179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
    Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
    J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers.
    Novobilský R; Bartova P; Lichá K; Bar M; Stejskal D; Kusnierova P
    Front Hum Neurosci; 2023; 17():1284416. PubMed ID: 38164192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer disease].
    He L; Zhang C; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):207-212. PubMed ID: 38595235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
    Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
    ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye.
    Bai J; Wan Z; Wang M; Wu X; Wang T; Zhang Y; Xue Y; Xu H; Peng Q
    Front Aging Neurosci; 2022; 14():1027705. PubMed ID: 36408096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.
    Jeppsson A; Sandelius Å; Zettergren A; Kern S; Skoog I; Blennow K; Zetterberg H; Wikkelsø C; Hellström P; Tullberg M
    Fluids Barriers CNS; 2023 Jul; 20(1):54. PubMed ID: 37415175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes.
    Li Q; Li Z; Han X; Shen X; Wang F; Bai L; Li Z; Zhang R; Wang Y; Zhu X
    Front Neurosci; 2022; 16():805953. PubMed ID: 35250451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China.
    Jiao B; Liu H; Guo L; Liao X; Zhou Y; Weng L; Xiao X; Zhou L; Wang X; Jiang Y; Yang Q; Zhu Y; Zhou L; Zhang W; Wang J; Yan X; Tang B; Shen L
    Front Aging Neurosci; 2021; 13():749649. PubMed ID: 34776933
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid β-amyloid
    Osborn KE; Liu D; Samuels LR; Moore EE; Cambronero FE; Acosta LMY; Bell SP; Babicz MA; Gordon EA; Pechman KR; Davis LT; Gifford KA; Hohman TJ; Blennow K; Zetterberg H; Jefferson AL
    Neurobiol Aging; 2018 Aug; 68():18-25. PubMed ID: 29702372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.